Launch
Website- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About us
Dr Arkenau specialises in Cancer Drug Development and is Executive Medical Director of Sarah Cannon Research UK (www.sarahcannonresearch.co.uk).
His tumour and research interest are Bowel, Stomach, Upper GI Cancer (Pancreas, Biliary Tree, oesophageal) and Melanoma.
Areas of interest
Gastrointestinal Oncology (Large and small Bowel, Stomach/Esophagus, Pancreas, Biliary Tree Cancers, HCC) Melanoma, Early Drug Development, Molecular Genetics, Phase-1-3 trials
Medical secretaries
- Jennifer Holland
- Sarah Cannon Research UK 93 Harley Street London W1G 6AD
- 020 3219 5200
- 020 3219 5250
- Jennifer.Holland2@hcahealthcare.co.uk
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (>50)
Harley Street Clinic (>50)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Harley Street Clinic (5-50)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
Harley Street Clinic (5-50)
-
AA842
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-14 days - (5-50)
-
AA844
Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-28 days - (5-50)
- Show All (6 )...